Administrative Core
行政核心
基本信息
- 批准号:8931832
- 负责人:
- 金额:$ 86.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-26 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdvocacyAdvocateBasic ScienceBiologyBostonCancer CenterClinicalClinical ResearchClinical TrialsCollaborationsCommunicationConflict (Psychology)ConsultationsDataDevelopmentDisputesEnsureEvaluationFoundationsFund RaisingFundingFutureGoalsGrantHospitalsHuman ResourcesHuman Subject ResearchInstitutionIsraelLaboratory FindingLeadershipMalignant neoplasm of lungMedicalMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPreparationPrincipal InvestigatorProgram EvaluationProgress ReportsPublicationsRegulationResearchResearch InfrastructureResearch PersonnelResearch PriorityResearch Project GrantsResourcesSeriesSourceTimeLineTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWorkYale Cancer Centeranticancer researchbasecareer developmentcost effectivemeetingsneoplasm resourcenoveloperationoutreachpersonalized medicinepre-clinicalprogramssuccessweb site
项目摘要
CORE SUMMARY
The Administrative Core (Core A) will be directed by Roy Herbst, Principal -Investigator of the Yale SPORE in
Lung Cancer (YSILC), and co-directed by Ed Kaftan, with support from the program financial management
team. Careful oversight by the Administrative Core will be critical to ensure the success of the Yale SPORE in
Lung Cancer. Core A is an extension of existing infrastructure provided by YCC Research Administration to
support and facilitate transdisciplinary research efforts. The Administrative Core serves as the central
coordination point for all YSILC investigators, with responsibility for monitoring the progress of all projects and
cores toward a translational/clinical endpoint. The Core Director and Co-Director along with the YSILC Co-PI
(Dr. Chen) will have responsibility for leading the YSILC program, setting translational research priorities,
identifying new translational research opportunities from emerging data, monitoring the progress of all projects,
cores and developmental projects and determining changes in direction of projects, cores and translational
research as needed. Interactions among YSILC investigators will be facilitated by Core A to accelerate the
translation of laboratory findings into the proposed and future clinical studies. If required, the Core A Director
will manage conflicts among YSILC investigators. As a team, the Core personnel will monitor finances,
maintain communications among project and core leaders and coordinate meetings, including the weekly lung
cancer translational group seminar series, monthly meetings of the Executive Committee, annual meetings of
the Internal/External Advisory boards and an annual YSILC retreat. In addition to these functions, the Core will
be the primary interface with the NCI, the Beth Israel Deaconess Medical Cancer Center, other lung cancer
SPOREs, Yale Cancer Center and Yale University, and will coordinate outreach efforts, including publications
(internal and external), website development, seminars, patient/research advocacy activities, and fundraising
programs. Through these administrative activities, Core A will be essential to the organization of the YSILC
program, to developing a widespread culture of lung cancer basic/clinical/translational research at Yale and to
the efficient achievement of the stated program objectives, with the ultimate goal of a significant clinical impact
for patients with lung cancer
核心摘要
行政核心(核心A)将由耶鲁孢子的主要投资人罗伊·赫布斯特(Roy Herbst)执导。
肺癌(YSILC),由Ed Kaftan共同执导,并得到计划财务管理的支持
团队。行政核心的仔细监督对于确保耶鲁孢子的成功至关重要
肺癌。核心A是YCC研究管理局提供的现有基础设施的扩展
支持和促进跨学科研究工作。行政核心是中央
所有YSILC调查人员的协调点,负责监视所有项目的进度和
朝向转化/临床终点的核心。核心主任和联合导演以及YSILC Co-Pi
(Chen博士)将负责领导YSILC计划,设定翻译研究重点,
从新兴数据中确定新的翻译研究机会,监视所有项目的进度,
核心和发展项目,并确定项目,核心和翻译方向的变化
根据需要进行研究。核心A将促进YSILC调查人员之间的相互作用,以加速
将实验室发现转换为拟议的和未来的临床研究。如果需要,核心董事
将管理YSILC调查人员之间的冲突。作为一个团队,核心人员将监控财务状况,
维持项目和核心领导者之间的沟通以及协调会议,包括每周肺
癌症转化小组研讨会系列,执行委员会的月度会议,年度会议
内部/外部咨询委员会和年度YSILC务虚会。除了这些功能,核心还将
成为NCI,贝丝以色列执事医疗癌中心的主要界面,其他肺癌
孢子,耶鲁大学癌症中心和耶鲁大学,将协调外展工作,包括出版物
(内部和外部),网站开发,研讨会,患者/研究倡导活动以及筹款活动
程序。通过这些行政活动,核心A对于YSILC的组织至关重要
计划,开发耶鲁大学肺癌基础/临床/翻译研究的广泛文化和
既定计划目标的有效成就,其最终目标是产生重大临床影响
对于肺癌患者
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roy S Herbst其他文献
Ultrastructural
- DOI:
10.1038/labinvest.2012.25 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:0
- 作者:
Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou;Konstantinos N Syrigos;Mario Sznol;Roy S Herbst;Scott N Gettinger;Lieping Chen;David L Rimm - 通讯作者:
David L Rimm
Pan-genomic/Pan-proteomic Approaches to Diseases
- DOI:
10.1038/labinvest.2012.19 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:0
- 作者:
Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou;Konstantinos N Syrigos;Mario Sznol;Roy S Herbst;Scott N Gettinger;Lieping Chen;David L Rimm - 通讯作者:
David L Rimm
Bone & Soft Tissue
- DOI:
10.1038/labinvest.2012.27 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:
- 作者:
Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou;Konstantinos N Syrigos;Mario Sznol;Roy S Herbst;Scott N Gettinger;Lieping Chen;David L Rimm - 通讯作者:
David L Rimm
Pathobiology
- DOI:
10.1038/labinvest.2012.20 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:0
- 作者:
Vamsidhar Velcheti;Kurt A Schalper;Daniel E Carvajal;Valsamo K Anagnostou;Konstantinos N Syrigos;Mario Sznol;Roy S Herbst;Scott N Gettinger;Lieping Chen;David L Rimm - 通讯作者:
David L Rimm
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol
在 Lung-MAP Master Protocol 中重新分析临床 DNA 测序数据以进行生物标志物匹配的过程
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
J.W. Neal;K. Minichiello;Ryan Brennick;Richard S P Huang;Matthew C. Hiemenz;Cornel Amler;Jyoti D. Patel;Roy S Herbst;K. Reckamp;Hossein Borghaei;Louise Highleyman;M. Redman;L. Pasquina;D. Kozono - 通讯作者:
D. Kozono
Roy S Herbst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roy S Herbst', 18)}}的其他基金
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
10203850 - 财政年份:2015
- 资助金额:
$ 86.07万 - 项目类别:
Yale SPORE in Lung Cancer Developmental Research Program
耶鲁大学 SPORE 肺癌发展研究项目
- 批准号:
10203857 - 财政年份:2015
- 资助金额:
$ 86.07万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
9767058 - 财政年份:2015
- 资助金额:
$ 86.07万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
9338869 - 财政年份:2015
- 资助金额:
$ 86.07万 - 项目类别:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
耶鲁 SPORE 肺癌 (YSILC):肺癌的生物学和个性化治疗
- 批准号:
8931829 - 财政年份:2015
- 资助金额:
$ 86.07万 - 项目类别:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
基于 MicroRNA 的干预措施可预防肺肿瘤前期发展为腺癌
- 批准号:
9379210 - 财政年份:2015
- 资助金额:
$ 86.07万 - 项目类别:
相似国自然基金
基于倡导促动理论的老年人多重慢病健康管理策略研究:理论模型、行为模式与管理路径
- 批准号:71874104
- 批准年份:2018
- 资助金额:50.0 万元
- 项目类别:面上项目
相似海外基金
myAURA: Personalized Web Service for Epilepsy Management
myAURA:用于癫痫管理的个性化 Web 服务
- 批准号:
10414826 - 财政年份:2021
- 资助金额:
$ 86.07万 - 项目类别:
Geriatric Oncology Research Infrastructure to Improve Clinical Care
改善临床护理的老年肿瘤学研究基础设施
- 批准号:
10667860 - 财政年份:2018
- 资助金额:
$ 86.07万 - 项目类别:
Core 3: Communications, Administrations, Advocacy, and Project Management
核心 3:沟通、行政、宣传和项目管理
- 批准号:
10628613 - 财政年份:2017
- 资助金额:
$ 86.07万 - 项目类别: